Forces that Shape and Constrain Medical Practice
Michelle Mello discusses how the law, artificial intelligence, and the COVID-19 pandemic have shaped health care.
Regulatory Collaboration to Protect Public Health
Noah Aleshire, chief regulatory officer at the CDC, discusses the value of a collaborative and informed regulatory process.
FDA Targets Toxic Soda Ingredients
FDA proposes a rule that would prohibit the use of a toxic food additive in sodas.
The Growing Crisis of Maternity Care Deserts
Scholars, politicians, and advocates expose maternal health care disparities and propose regulatory solutions.
Access Barriers Remain After Abortion Pill Decision
The Court rejected a challenge to FDA approval of mifepristone, but other obstacles could still impede access.
Establishing Regulatory Guardrails for Elderly Drivers
Scholars urge state lawmakers to strengthen driving regulations for seniors to address public safety concerns.
Regulating Off-Label Prescribing
Scholars and practitioners debate whether and how to regulate off-label drug use.
Off-Label Drug Use Liability
Scholar argues that FDA approval should not save drug makers from state-law claims arising from off-label use.
The Future of Plant-Based Meats
Scholar recommends that regulators change food label laws to increase consumers’ access to plant-based meats.
Organ Transplantation System Modernization
UNOS may no longer retain sole control of the organ transplantation network.
Editing the Human Genome
Scholars assess global regulatory practices concerning human genome editing.